학술논문

Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study
Document Type
Article
Source
In: eBioMedicine. (eBioMedicine, August 2023, 94)
Subject
Language
English
ISSN
23523964